Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

Juno Therapeutics Cmn (NASDAQ: JUNO)


Last Updated: Feb-21-2017 12:56:42

Premium Research

Juno Therapeutics Cmn (NASDAQ: JUNO) Profile

Volume457,449
Open$23.13
Prior Close$23.13
Market Cap$2.45 B
PE Ratio
Beta2.27
Juno Therapeutics Inc. is a biopharmaceutical company. The Company develops cellular immunotherapies based on two platforms - Chimeric Antigen Receptors (CARs) and T Cell Receptors (TCRs) technologies. Its clinical CD19 product candidates include JCAR015 that is in Phase I clinical trials for adult patients with relapsed/refractory B cell acute lymphoblastic leukemia (r/r ALL); JCAR017 which is in Phase I/II trials for pediatric patients with r/r ALL whose cancer has recurred after a bone marrow transplant; and JCAR014 that is in Phase I/II trials to treat various B cell malignancies in patients relapsed or refractory to standard therapies. Juno Therapeutics Inc. is headquartered in Seattle Washington.
SymbolCompanyMarket cap
AMGNAmgen$126.75 B
CELGCelgene Corp$92.31 B
GILDGilead Sciences Inc$92.11 B
BIIBBiogen Inc Cmn$62.65 B
REGNRegeneron Pharmaceutical$39.34 B
BXLTBaxalta Incorporated Common Sto$31.46 B
ALXNAlexion Pharm Inc$29.2 B
ILMNIllumina Inc$23.6 B
INCYIncyte Corporation$22.76 B
VRTXVertex Pharmaceutic$21.78 B

JUNO Earnings

1st Quarter Earnings$-0.57 (2016-11-09)
2nd Quarter Earnings$-0.64 (2016-08-04)
3rd Quarter Earnings$-0.78 (2016-05-09)
4th Quarter Earnings$-0.53 (2016-02-29)
PE Ratio0
EPS Growth-15.63%
Recent Earnings$-0.57
Annual EPS$-2.56
Market Capitalization$2.45 B
Insider Shareholder %0.1526%
Annual Revenue$0.06 B
Number of Shares Outstanding105,870 Shares
Institutional Shareholder %61.8%
Annual Net Income$0B
TTM Net Profit Margin$102.53
One Year Return-35.06%
Three Year Return-33.91%
Five Year Return-33.91%
Five Year Revenue Growth0%
Five Year Earnings Growth0%
Five Year Dividend Growth0%
Last Quarter EPS$-0.56
Annual EPS$-2.56
Annual Dividend$0
Annual Dividend Yield0%
Change in EPS YTD-15.63%
PE Ratio
Recent Earnings$-0.57
Dividends per Share$
Stock Split Ratio
beta2.27

JUNO Key Stats

Last Price$23.11
Net Change$-0.02 (-0.09%)
Bid$23.11
Ask Price$23.13
Open Price$23.13
Previous Close Price$23.13
High Price$23.5
Low Price$22.92
Number of Trades2,274
Volume457,449
Fifty Two Week High$49.72 (2016-06-06)
Fifty Two Week Low$17.52 (2016-12-22)
Average Daily Volume1,436,206
Share Outstanding105,870 Shares
Total Dividend Payout$0/yr
Dividend Yield0%